| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Trevi Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 175,000 | 15 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics, Inc. | 15 Feb 2024 | 1 | $0 | 4 | Chief Medical Officer | 16 Feb 2024, 16:43 |
| TRVI | Trevi Therapeutics, Inc. | 14 Nov 2022 | 1 | $0 | 4 | Chief Medical Officer | 14 Nov 2022, 15:43 |
| TRVI | Trevi Therapeutics, Inc. | 14 Nov 2022 | 0 | $0 | 3 | Chief Medical Officer | 14 Nov 2022, 15:30 |